Dynavax Technologies
DVAX
#4911
Rank
HK$14.30 B
Marketcap
HK$121.80
Share price
0.13%
Change (1 day)
25.36%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: HK$14.30 Billion

As of January 2026 Dynavax Technologies has a market cap of HK$14.30 Billion. This makes Dynavax Technologies the world's 4911th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$14.30 B1.78%
2025HK$14.05 B5.91%
2024HK$13.26 B-6%
2023HK$14.11 B33.06%
2022HK$10.60 B-19.4%
2021HK$13.16 B246.21%
2020HK$3.80 B1.74%
2019HK$3.73 B-17.05%
2018HK$4.50 B-49.12%
2017HK$8.85 B650.2%
2016HK$1.18 B-83.61%
2015HK$7.19 B109.26%
2014HK$3.44 B-13.87%
2013HK$3.99 B-1.09%
2012HK$4.03 B23.49%
2011HK$3.26 B13.58%
2010HK$2.87 B381.75%
2009HK$0.59 B131.01%
2008HK$0.25 B-83.67%
2007HK$1.58 B-44.13%
2006HK$2.83 B266.95%
2005HK$0.77 B-47.5%
2004HK$1.47 B

End of Day market cap according to different sources

On Jan 15th, 2026 the market cap of Dynavax Technologies was reported to be:

HK$14.30 Billion
by Nasdaq info icon info icon
HK$14.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
HK$0.97 B-93.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$192.82 B 1,248.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.161 T 15,011.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$1.173 T 8,103.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.272 T 15,788.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
HK$774.07 B 5,312.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$1.147 T 7,925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$289.39 B 1,923.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.385 T 9,589.07%๐Ÿ‡บ๐Ÿ‡ธ USA